Ekso Bionics (EKSO) Competitors

Ekso Bionics (NASDAQ:EKSO) and Tungray Technologies (NASDAQ:TRSG) are both small-cap machinery companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, valuation, risk, earnings, media sentiment, institutional ownership and dividends.

Does the media refer more to EKSO or TRSG?

In the previous week, Ekso Bionics and Ekso Bionics both had 1 articles in the media. Ekso Bionics' average media sentiment score of 1.89 beat Tungray Technologies' score of 1.87 indicating that Ekso Bionics is being referred to more favorably in the media.

Company	Overall Sentiment
Ekso Bionics	Very Positive
Tungray Technologies	Very Positive

Which has more volatility & risk, EKSO or TRSG?

Ekso Bionics has a beta of 0.81, indicating that its stock price is 19% less volatile than the S&P 500. Comparatively, Tungray Technologies has a beta of 1.05, indicating that its stock price is 5% more volatile than the S&P 500.

Which has better earnings & valuation, EKSO or TRSG?

Tungray Technologies has lower revenue, but higher earnings than Ekso Bionics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ekso Bionics	$17.54M	0.43	-$11.33M	-$7.35	-0.44
Tungray Technologies	$12.81M	2.21	N/A	N/A	N/A

Do insiders and institutionals hold more shares of EKSO or TRSG?

6.4% of Ekso Bionics shares are held by institutional investors. 6.1% of Ekso Bionics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Do analysts prefer EKSO or TRSG?

Ekso Bionics currently has a consensus price target of $562.50, suggesting a potential upside of 17,368.94%. Given Ekso Bionics' stronger consensus rating and higher probable upside, research analysts clearly believe Ekso Bionics is more favorable than Tungray Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ekso Bionics	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Tungray Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Is EKSO or TRSG more profitable?

Tungray Technologies has a net margin of 0.00% compared to Ekso Bionics' net margin of -61.51%. Tungray Technologies' return on equity of 0.00% beat Ekso Bionics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ekso Bionics	-61.51%	-82.50%	-39.19%
Tungray Technologies	N/A	N/A	N/A

Summary

Ekso Bionics beats Tungray Technologies on 7 of the 12 factors compared between the two stocks.